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Dear colleague 
 
This is the third Newsletter for members of the EAVLD. 
The first two Newsletters were sent to members in May 
and December 2010. They are available on the EAVLD 
website www.eavld.org under Member pages. 
 
In this issue we present some information about  
Matrix Assisted Laser Desorption / Ionization Time-of-
flight (Maldi-TOF) mass spectrometry as a tool for the 
identification of micro-organisms, diagnosis of pandemic 
influenza A H1N1 virus in Danish pigs and tumour diag-
nosis of dogs and cats in relation to veterinary oncology. 
 
At the end of the Newsletter you find a list of the EAVLD 
board members. 
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This newsletter... 
EAVLD NEWS 
EAVLD Congress 2012 in Poland 
In 2010, the first EAVLD Congress was successfully held in the Netherlands, with more than 250 sci-
entists visiting this congress. The second EAVLD Congress will be held in Poland, in 2012, and will be 
organized by the National Veterinary Research Institute (NVRI) in Pulawy. The NVRI has experience in 
hosted congresses and large meetings, showing an excellent organisation talent. More information will 
become available soon and EAVLD members will be kept informed on the progress of the organisation 
of this congress. 
 
New website layout 
As you may have noticed the appearance of the website has changed. The reason is that we decided 
to change program to build the website in order to facilitate administration and improve the visual ap-
pearance. NB: Members login can be found in the upper right corner! 
 
A new feature of the website is the PayPal button that simplifies payment for membership using credit 
cards. We hope that this will be helpful. Now, as payment options have been improved, new members 
will have to pay before being allowed into the member pages.  
 
In order to facilitate the interaction between members we have now started a discussion page for 
members. The members are strongly encouraged to make use of this discussion forum and to come 
up with proposals for activities on the website. If you experience any problems with the website, 
please report to Frederik.Widén@sva.se  
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Matrix-Assisted Laser Desorption/Ionization (MALDI) is a soft ionization technique used in mass 
spectrometry, allowing the analysis of biomolecules (biopolymers such as proteins, peptides and 
sugars) and large organic molecules (such as polymers, dendrimers and other macromolecules), 
which tend to be fragile and fragment when ionized by more conventional ionization methods. The 
ionization is triggered by a laser beam (1). The type of a mass spectrometer most widely used with 
MALDI is the TOF (Time-Of-Flight mass spectrometer), mainly due to its large mass range. 
MALDI-(TOF) is used in biochemistry, organic chemistry, polymer chemistry but also in microbiology. 
MALDI-TOF spectra can be used for the identification of micro-organisms such as bacteria or fungi. 
Species diagnosis by this procedure is much faster, more accurate and cheaper than other proce-
dures based on immunological or biochemical tests (3). 
 
Identification of micro-organisms by Maldi-TOF  
Fast and reliable identification of micro-organisms is a crucial step toward an appropriate treatment 
of infectious diseases in medical and veterinary diagnostics and is of main interest today. Mass spec-
tral identification of micro-organisms has been shown as a tool for rapid identification. Identification 
of micro-organisms by MALDI-TOF-MS can be applied to a wide array of bacteria, yeasts, and 
moulds. A small amount of cells from a plate is sufficient for an automated and rapid identification 
(2, 3).  
 
Procedure for the identification of micro-organisms 
The sample preparation is very simple and easy to perform. After selection of the colony of interest, 
the colony is removed from the culture plate and dissolved in acetonitrile. A small volume is placed 
on a steel target surface and dried by air. After drying, the steel target surface is placed in the Maldi-
TOF mass spectrometer, and mass-spectra are collected. The mass-spectra of the unknown micro-
organism will be compared with known bacterial reference strains in the database (Figure 1). 
 
Conclusion 
MALDI TOF-MS is a valuable tool in biosciences for obtaining accurate mass determinations, primary 
sequence information, and it can also be used or the identification of micro-organisms. Validation 
studies have shown that the species diagnosis by MALDI-TOF is much faster, more accurate and 
cheaper than other procedures based on immunological or biochemical tests. Therefore, MALDI-TOF 
may or will become the standard method for species identification in medical microbiological labora-
tories over the next few years. However, it is of great importance that the MALDI-TOF database con-
tains as much as possible bacterial reference strains, not only from human origin but also from  
veterinary origin. Therefore, co-operation is needed between the different labs to enlarge the data-
Matrix Assisted Laser Desorption / Ionization Time-of-
flight (Maldi-TOF) Mass Spectrometry and the 
identification of micro-organisms 
To be continued on next page.. 
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base for the identification of micro-organisms from veterinary origin.  
If institutes/laboratories are interested in co-operation, please contact; 
g.wellenberg@gddeventer.com 
 
References 
1: http://en.wikipedia.org/wiki/Matrix-assisted_laser_desorption/ionization 
 
2: Alispahic M., et al., VetOMICS, 2008. 
 
3: Seng P, Drancourt M, Gouriet F, La Scola B, Fournier PE, Rolain JM, Raoult D. 2009. "Ongoing 
revolution in bacteriology: routine identification of bacteria by matrix-assisted laser desorption ioni-
zation time-of-flight mass spectrometry." Clin Infect Dis. 49 (4): 552–3. 
 
Gerard Wellenberg 
GD-Deventer 
Figure 1: 
Spectra of Arcobacter butzleri, Campylobacter jejuni, and Helicobacter pullorum (Figure presented 
by reference 2). 
Continued... 
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Influenza subtypes H1N1, H3N2 and H1N2 are circulating in pig populations worldwide. In March-
April 2009, a novel pandemic Influenza A H1N1 virus (H1N1-2009v) of swine origin emerged in the 
human population globally and subsequently has also been diagnosed in pigs from several countries. 
The H1N1-2009v virus differs genetically from the swine H1N1 viruses that have been circulating in 
pigs worldwide for decades, thus diagnostic assays for swine influenza virus needed validation to as-
sure detection of the new H1N1-2009v virus. 
  
At the National Veterinary Institute in Denmark, detection of swine influenza virus in clinical speci-
mens is routinely performed by real-time RT-PCR targeting the M or NP genes. These assays have 
been validated for detection of the H1N1-2009v virus by in silico analysis of primer and probe target 
regions and by testing known positive samples of human origin. Thus, it has been confirmed that 
these assays also detect the new variant virus, and are unable to discriminate between the previ-
ously circulating strains and the H1N1-2009v variant. 
 
For specific detection of the H1N1-2009v subtype, a real-time RT-PCR assay targeting specifically the 
HA gene of the H1N1-2009v virus that was developed for human diagnosis of H1N1-2009v at the 
State Serum Institute, was validated on archived influenza virus positive swine samples. The assay 
turned out to be specific for the H1N1-2009v subtype only. 
 
Since 2009, the diagnostic strategy at the national Veterinary Institute has been to routinely subtype 
all samples that are positive for swine influenza virus by M and/or NP real-time RT-PCR, with the 
H1N1-2009v specific assay. The first case of H1N1-2009v in a Danish pig herd was diagnosed in 
January 2010, and since then approximately 10 % of the swine influenza virus positive herds are of 
this subtype. Thus, the H1N1-2009v virus appears to have become established in the Danish pig 
population together with the previously recognized swine influenza subtypes. 
 
By Charlotte K Hjulsager, National Veterinary Institute, Technical University of Denmark. 
YEAR SIV 
positive herds 
H1N1-2009v 
positive herds 
2009 81 0 
2010 96 9 
2011* 47 10 
Number of Danish herds diagnosed posi-
tive for swine influenza virus (SIV) and 
H1N1-2009v at the National Veterinary 
Institute, Technical University of Denmark 
until May 1st 2011* 
Diagnosis of Pandemic Influenza A H1N1 virus  
in Danish pigs 
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Tumour diagnosis of dogs and cats: The new area of 
veterinary oncology 
within the veterinary oncology laboratory, and 
new techniques are introduced to improve the 
quality. Technological innovations, such as the 
introduction of DNA techniques, and the use of 
the special staining techniques, KI 67 and Ag-
NOR, have found their ways within our labora-
tory. Staining techniques in the immunocytopa-
thology can be used for the identification of 
malignant lymphoma’s; to investigate the ex-
pression of CD3 or CD79a by these lym-
phoma’s. Based on these techniques it is possi-
ble to examine whether we have to deal with a 
T-cell of B-cell lymphoma. 
   
As you will understand, the field of veterinary 
oncology is moving quickly forward. It follows 
the new developments within the human oncol-
ogy like a shadow. This new area is improving 
more and more as owners of dogs and cats 
would like to give their pets the best possible 
treatment. 
 
Gerard Wellenberg 
GD-Deventer 
The number of dogs and cats in each country is 
high. For example in the UK, there are 6.8 mil-
lion dogs and 9.6 million cats, and in The Neth-
erlands 2.1 million dogs and 3.6 million cats.  
 
Dogs and cats are becoming more and more 
family members. Their living standard and con-
sequently their lifetime have increased the past 
decade. Due to a longer lifetime, more and 
more dogs and cats will develop tumours. 
Nowadays, one of each three dogs and cats in 
The Netherlands will develop cancer, which 
means more than 100.000 new cases every 
year. 
 
Owners of dogs and cats ask for more exten-
sive diagnostic investigations concerning all 
kind of diseases. This includes more specific 
tumour diagnosis in order to find the best 
treatment for their pet. With the right diagno-
sis, veterinary practitioners can start a discus-
sion, together with the owners, how to treat 
the tumour. 
 
New opportunities for treatment also ask for 
higher standards of pathological investigations. 
Pathological investigations, based on micro-
scopic parameters, can give answers on the 
type of tumour, e.g. benign or malignant, and 
it can open new ways for treatment. Based on 
the right diagnosis, the vet can make more 
strategic choices for treatment. 
 
In well equipped and occupied veterinary on-
cology labs, different kind of materials and 
samples can be investigated to search for the 
right diagnosis concerning tumours and skin 
lesions. Cytological, immunocytological and 
histopathogical investigations are widely used 
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 President: Andrew Soldan, VLA, UK 
 Secretary and Vice President: Willie Loeffen, CVI, The Netherlands 
 Treasurer:  Frederik Widén, SVA, Sweden 
 Martin Beer, Friedrich-Loeffler-Institut, Germany 
 Sven Erik Jorsal, Danish Technical University, Denmark  
 Tadeusz Wijaszka, National Veterinary Research Institute, Poland 
 Jose Antonio Garcia, Universidad Complutense, Spain 
 Gerard Wellenberg, Dutch Animal Health Service, The Netherlands 
 
Gerard Wellenberg was elected as a new member of the board at the general meeting in the Nether-
lands in September 2010. 
 
 
 
 
EAVLD Board  
You can read short presentations of the 
other board members in the first News-
letter which you can find on the home-
page: http://www.eavld.org/
attachments/Newsletter/
EAVLD_Newsletter_1_2010-04-19.pdf  
(NB logon for members is needed) 
Short presentation 
Gerard Wellenberg was born on July 20, 1958. Gerard 
studied Medical Microbiology in Deventer, The Nether-
lands. He started his active career at the Regional 
Medical Health Laboratory and the Regional Animal 
Health Services in 1977 and 1980, respectively. During 
this period, he studied Immunology and Biochemistry 
at the Open University in The Netherlands. In the pe-
riod 1992 – 1994, he studied Medical Biology at the 
University of Groningen. In the next two years, he was 
setting up an ELISA laboratory at Pharma-Bio Re-
search, a Clinical Pharmaceutical and Biomedical Re-
search centre for the registration of pharmaceutical 
compounds at the FDA. 
 
He became head of one of the laboratory units within 
the Virology Department at ID-DLO (Lelystad) in 1996. 
Gerard fulfilled his PhD study on the role of viruses in 
the aetiology of bovine mastitis in 2002.  
 
From 2005 on, he is senior scientist in Molecular Biol-
ogy and Virology at the Dutch Animal Health Service in 
Deventer. Since 2001, he is also active as veterinary 
consultant in national and international projects.  
